It will offer more protection against bleeding and instead of requiring vein access, it is injected under the skin , once a week, or once every two weeks.
The standard treatment for the past 40 years has been based on intravenous injections of the missing clotting factor.In 2018, an improved form of the intravenous injection was introduced, which could be infused twice per week.
Fantastic news. We'll done for funding Hemlibra
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: